L Berk

407 total citations
14 papers, 230 citations indexed

About

L Berk is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, L Berk has authored 14 papers receiving a total of 230 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 3 papers in Oncology. Recurrent topics in L Berk's work include Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). L Berk is often cited by papers focused on Hepatitis C virus research (8 papers), Hepatitis B Virus Studies (6 papers) and Liver Disease Diagnosis and Treatment (4 papers). L Berk collaborates with scholars based in Netherlands, Belgium and Germany. L Berk's co-authors include Solko W. Schalm, R. A. Heijtink, Erik De Clercq, Jan Balzarini, Antonı́n Holý, J. Kruining, Harry L.A. Janssen, Rudolf A. Heijtink, Rob A. de Man and P. Berthelot and has published in prestigious journals such as Gut, Journal of Hepatology and Antiviral Research.

In The Last Decade

L Berk

13 papers receiving 222 citations

Peers

L Berk

EPIDE

HEPAT

ID

PRM

ONCOL

MY Maïga Mali

Wolfgang Kauffmann Germany

Dietmar M. Klass Germany

Malte B. Monin Germany

Oon Cj Singapore

G Felten Germany

Jianning Jiang China

Simon B. Larsson Sweden

Carlotta Cerva Italy

Judit Vidal‐González Spain

MY Maïga Mali

L Berk

259 ×1.6

EPIDE

241 ×1.8

HEPAT

26 ×0.4

ID

8 ×0.3

PRM

5 ×0.2

ONCOL

Citations per year, relative to L Berk L Berk (= 1×) peers MY Maïga

Countries citing papers authored by L Berk

Since Specialization

Citations

This map shows the geographic impact of L Berk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Berk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Berk more than expected).

Fields of papers citing papers by L Berk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Berk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Berk. The network helps show where L Berk may publish in the future.

Co-authorship network of co-authors of L Berk

This figure shows the co-authorship network connecting the top 25 collaborators of L Berk. A scholar is included among the top collaborators of L Berk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Berk. L Berk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Backes, Yara, Leon M.G. Moons, Jeroen D. van Bergeijk, et al.. (2016). Endoscopic mucosal resection (EMR) versus endoscopic submucosal dissection (ESD) for resection of large distal non-pedunculated colorectal adenomas (MATILDA-trial): rationale and design of a multicenter randomized clinical trial. BMC Gastroenterology. 16(1). 56–56. 31 indexed citations

2.

Elshout, Gijs, Frank J. M. F. Dor, L.C. Verhoog, L Berk, & W. W. Vrijland. (2010). A Dutch patient presenting with a rare clinical syndrome. Gut. 60(9). 1213–1213. 1 indexed citations

3.

Berk, L, Arthur R. Van Gool, M. Bannink, & Wim H.J. Kruit. (1999). [Side effects of interferon alfa].. PubMed. 143(28). 1461–4. 3 indexed citations

4.

Gool, Arthur R. Van, Wim H.J. Kruit, J.J. Cornelissen, et al.. (1999). Management of psychiatric adverse events with immunotherapy with interferon-alfa. Acta Neuropsychiatrica. 11(4). 120–124. 8 indexed citations

5.

Heijtink, R. A., J. Kruining, L Berk, et al.. (1993). Inhibitory effect of 9-(2-phosphonylmethoxyethyl)adenine (PMEA) on human and duck hepatitis B virus infection. Antiviral Research. 21(2). 141–153. 97 indexed citations

6.

Janssen, Harry L.A., et al.. (1993). Repeated courses of α-interferon for treatment of chronic hepatitis type B. Journal of Hepatology. 17. S47–S51. 27 indexed citations

7.

Janssen, Harry L.A., L Berk, Solko W. Schalm, et al.. (1992). Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.. Gut. 33(8). 1094–1098. 22 indexed citations

8.

Berk, L, et al.. (1992). [Alpha-interferon antiviral treatment in 100 patients with chronic hepatitis B].. PubMed. 136(17). 835–9. 1 indexed citations

9.

Berk, L, Solko W. Schalm, & R. A. Heijtink. (1991). Severe chronic active hepatitis (autoimmune type) mimicked by coinfection of hepatitis C and human immunodeficiency viruses.. Gut. 32(10). 1198–1200. 13 indexed citations

10.

Man, Robert A. de, et al.. (1991). Treatment of Chronic Viral Hepatitis. Digestive Diseases. 9(1). 17–35. 3 indexed citations

11.

Berk, L, et al.. (1991). Alpha lymphoblastoid interferon and acyclovir for chronic hepatitis delta.. PubMed. 364. 411–20. 13 indexed citations

12.

Berk, L, et al.. (1991). The antiviral effect of repeated courses of alpha interferon treatment in chronic hepatitis B. Journal of Hepatology. 13. S37–S37. 1 indexed citations

13.

Man, Robert A. de, et al.. (1988). Long-term follow-up of antiviral combination therapy in chronic hepatitis B.. PubMed. 85(2A). 150–4. 10 indexed citations

14.

Mario, Carlo Di, et al.. (1988). Synchronized diastolic coronary sinus retroperfusion. Technique, physiologic and experimental basis, clinical experience, future perspectives.. PubMed. 33(11). 1017–22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact